2m 2m 2m 2m 2m 2m 2m
AMNEAL PHRMCTL-A (AMRX)
NASDAQ
$18.00+$0.09 (+0.52%)
Price as of Aug 21, 2026 7:56 PM EDT- $6.2BMarket Cap
- 86.76%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AMNEAL PHRMCTL-A (AMRX)
$18.00+$0.09 (+0.52%)
AMRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.91 | ||
Change | +$0.01 (+0.06%) | ||
Open | $17.99 | ||
High | $18.12 | ||
Low | $17.77 | ||
Previous Close | $17.90 | ||
Volume | 1,365,526 | ||
30-Day Average Volume | 1,834,072 | ||
1-Week Change | -1.32% | ||
1-Month Change | -1.05% | ||
1-Year Change | 86.76% | ||
3-Year Change | 370.08% | ||
5-Year Change | 269.28% | ||
Fundamentals | |||
Shares Outstanding | 348.3M | ||
Total Assets | $3.8B | ||
Market Cap | $6.2B | ||
Enterprise Value | $8.8B | ||
Period: QTR TTM FY | |||
Revenue | $796.2M | ||
Net Income | $57.7M | ||
Free Cash Flow | -$51.9M | ||
EBIT | $114.1M | ||
EBITDA | $149.0M | ||
Net Working Capital | $1.1B | ||
EPS | $0.18 | ||
Enterprise Value/EBITDA | 59 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 189 | ||
P/E | 99 | ||
PEG | -19 | ||
Price/Free Cash Flow | -120 | ||
Price/Operating Cash Flow | -294 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/26/2013 | ||
Earnings & Revenue